EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

The risk of chronic kidney disease development in adult patients with chronic hypoparathyroidism treated with rhPTH(1‐84): A retrospective cohort study

Lars Rejnmark iD, Olulade Ayodele, Angela Lax, Fan Mu, Elyse Swallow, Elvira O Gosmanova iD

Clinical Endocrinology · 2023-04 · 98 (4) · 496-504

DOI: 10.1111/cen.14813 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Endocrinology, online erschienen am 28.08.2022. Verfasst von Lars Rejnmark und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Internal Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Hypoparathyroidism, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study assessed the risk of developing chronic kidney disease (CKD) and decline in estimated glomerular filtration rate (eGFR) over a period of up to 5 years in adult patients with chronic hypoparathyroidism treated with recombinant human parathyroid hormone (1‐84) (rhPTH[1‐84]) compared with a historical control cohort of patients not treated with rhPTH(1‐84).

Design

Retrospective cohort study of patients with chronic hypoparathyroidism treated with rhPTH(1‐84) derived from the REPLACE (NCT00732615), RELAY (NCT01268098), RACE (NCT01297309) and HEXT (NCT01199614, and its continuation study NCT02910466) clinical trials and a historical control cohort who did not receive PTH selected from an electronic medical record database. Patients One hundred and eighteen patients treated with rhPTH(1‐84) and 497 patient controls.

Measurements

Incident CKD was defined as ≥2 eGFR measurements

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypoparathyroidismRenal Insufficiency, ChronicHumansAdultRetrospective StudiesParathyroid HormoneGlomerular Filtration Rate

Stichwörter der Autor:innen

chronic kidney diseaseglomerular filtration ratehypoparathyroidismparathyroid hormonerenal insufficiency

Substanzen

Parathyroid Hormone

Autor:innen und Institutionen

  • Department of Endocrinology and Internal Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.
  • Takeda Pharmaceuticals USA, Inc., Lexington, Massachusetts, USA.
  • Analysis Group, Inc., Boston, Massachusetts, USA.
  • Division of Nephrology and Hypertension, Albany Medical College, Albany, New York, USA.

ORCID-Profile: Lars Rejnmark, Elvira O Gosmanova

Zitieren

APA

Rejnmark, L., Ayodele, O., Lax, A., Mu, F., Swallow, E., & Gosmanova, E. O. (2023). The risk of chronic kidney disease development in adult patients with chronic hypoparathyroidism treated with rhPTH(1‐84): A retrospective cohort study. Clinical Endocrinology, 98(4), 496-504. https://doi.org/10.1111/cen.14813

Vancouver

Rejnmark L, Ayodele O, Lax A, Mu F, Swallow E, Gosmanova EO. The risk of chronic kidney disease development in adult patients with chronic hypoparathyroidism treated with rhPTH(1‐84): A retrospective cohort study. Clinical Endocrinology. 2023;98(4):496-504. doi:10.1111/cen.14813

BibTeX
@article{Rejnmark2023,
  author = {Rejnmark, Lars and Ayodele, Olulade and Lax, Angela and Mu, Fan and Swallow, Elyse and Gosmanova, Elvira O},
  title = {The risk of chronic kidney disease development in adult patients with chronic hypoparathyroidism treated with rhPTH(1‐84): A retrospective cohort study},
  journal = {Clinical Endocrinology},
  year = {2023},
  volume = {98},
  number = {4},
  pages = {496--504},
  doi = {10.1111/cen.14813}
}
Kostenlos starten →